Table 3. Association of genotypes with the expression of type III HLP.

	Type III HLP, N (%)	Normo, N (%)	OR (95% CI)	P-value
APOC3 3238 G>C
1/1	78 (69.6)	44 (86.3)	2.7 (1.1–6.7)	0.03
1/2+2/2	34 (30.4)	7 (13.7)
APOA5 −1131 T>C
1/1	75 (70.8)	45 (88.2)	3.1 (1.2–8.0)	0.02
1/2+2/2	31 (29.2)	6 (11.8)
APOA5 c.56 G>C
1/1	84 (79.2)	46 (90.2)	2.4 (0.9–6.7)	0.12
1/2+2/2	22 (20.8)	5 (9.8)
LPL c.27 G>A
1/1	100 (88.5)	51 (98.1)	6.6 (0.8–52.1)	0.07
1/2+2/2	13 (11.5)	1 (1.9)
Cumulative ¥
Non-carrier	48 (42.5)	38 (73.1)	3.7 (1.8–7.5)	<0.0001
Carrier	65 (57.5)	14 (26.9)

Type III HLP: type III hyperlipidemic patients; normo: normolipidemic E2/2 subjects; OR: odds ratio; 95% CI: 95% confidence interval; 1/1, homozygous for the common allele; 1/2 heterozygous for the common and rare allele; 2/2, homozygous for the rare allele; cumulative ¥: non-carrier represents non-carrier of the rare allele of either the APOA5 c.56 G>C, SNP3, APOC3 −1131 T>C or LPL c.27 G>A and carrier represents carrier of the rare allele of either the APOA5 c.56 G>C, SNP3, APOC3 −1131 T>C or LPL c.27 G>A.